Health Score

0 Good

Metadata coverage

Abstract

ORCID

References

License

Extended metadata coverage

Informational — signals of interoperability and funding across the corpus. Not part of the health score.

Funding

Funder

Award / grant

Affiliation & institutional identifiers

Affiliation

ROR ID

Update policy

Your prioritized action plan

Ordered by how many DOIs each fix touches — start here, not with every error at once.

Attach ORCID iDs across 706 articles

ORCID iDs strengthen author disambiguation and institutional reporting.

High impact706 DOIs

Deposit reference lists for 664 records

Deposited references power Crossref's Cited-by links between your articles and the literature.

Medium impact664 DOIs

Add abstracts to 208 articles

Abstracts are what surface your work in Google Scholar, Dimensions, and OpenAlex.

Low impact208 DOIs

DOIs for this ISSN

Showing the top 5 of 1329 DOIs, ordered by correction priority.

#	Title	Missing	Priority	Citations
1	Canadian Association of Gastroenterology Position Statement:… (10.1155/2014/346590)	Abstract References ORCID	109.68	28
2	Biomarkers in Nonalcoholic Fatty Liver Disease (10.1155/2014/757929)	References ORCID	107.92	143
3	Corticotropin‐Releasing Factor and the Brain‐Gut Motor Respo… (10.1155/1999/375916)	References ORCID	103.41	116
4	Thrombocytopenia in Liver Disease (10.1155/2000/617428)	References ORCID	103.03	114
5	Burden of Disease and Cost of Chronic Hepatitis C Virus Infe… (10.1155/2014/317623)	References ORCID	102.46	111
6	Abernethy Malformation: Congenital Absence of the Portal Vei… (10.1155/2014/675812)	Abstract References ORCID	102.13	22
7	Bacterial Glycosulphatases and Sulphomucin Degradation (10.1155/1997/642360)	References ORCID	100.22	100
8	The Pathophysiology of Chronic Constipation (10.1155/2011/169319)	References ORCID	100.22	100
9	Methotrexate Hepatotoxicity in Psoriatics: Report of 104 Pat… (10.1155/1996/213596)	References ORCID	99.11	95
10	Mesalazine in Inflammatory Bowel Disease: A Trendy Topic Onc… (10.1155/2010/586092)	References ORCID	96.47	84
11	Safety and Efficacy of Hemospray<sup>®</sup>in Upper Gastroi… (10.1155/2014/759436)	References ORCID	96.21	83
12	Clinicians’ Guide to the Use of Fecal Calprotectin to Identi… (10.1155/2015/852723)	References ORCID	92.87	71
13	Living with Inflammatory Bowel Disease: A Crohn’s and Coliti… (10.1155/2015/815820)	References ORCID	90.98	65
14	Complementary and Alternative Medicine Use by Patients with… (10.1155/1999/586765)	References ORCID	90.65	64
15	Systematic Review of Stimulant and Nonstimulant Laxatives fo… (10.1155/2014/631740)	References ORCID	90.65	64
16	Cholestatic Hepatocellular Injury with Azathioprine: A Case… (10.1155/1998/294752)	References ORCID	90.31	63
17	How Can the Current Strategies for <i>Helicobacter pylori</i… (10.1155/2003/714124)	References ORCID	90.31	63
18	Fecal Calprotectin Use in Inflammatory Bowel Disease and Bey… (10.1155/2015/950286)	References ORCID	89.97	62
19	Endoscopic Transmural Necrosectomy for Walled-Off Pancreatic… (10.1155/2014/539783)	References ORCID	89.62	61
20	The Impact of Patient Education on the Quality of Inpatient… (10.1155/2010/718628)	References ORCID	89.27	60
21	Hepatitis C Drugs: The End of the Pegylated Interferon Era a… (10.1155/2014/549624)	References ORCID	89.27	60
22	Endoscopic Mucosal Resection for Esophageal and Gastric Muco… (10.1155/1998/535978)	References ORCID	88.54	58
23	An Update on the Management of Chronic Hepatitis C: 2015 Con… (10.1155/2015/692408)	References ORCID	88.54	58
24	Influence of Sex and Disease on Illness‐Related Concerns in… (10.1155/1999/701645)	References ORCID	88.17	57
25	Predictors of Relapse to Significant Alcohol Drinking after… (10.1155/2010/596246)	References ORCID	88.17	57
26	High Prevalence of Esophageal Dysmotility in Asymptomatic Ob… (10.1155/2014/960520)	References ORCID	88.17	57
27	Effects of Inflammatory Mediators on Gut Sensititvity (10.1155/1999/846809)	References ORCID	87.41	55
28	Defining Quality Indicators for Best-Practice Management of… (10.1155/2014/941245)	References ORCID	86.62	53
29	Tax-Deductible Provisions for Gluten-Free Diet in Canada Com… (10.1155/2015/508156)	References ORCID	86.21	52
30	Treatment of Sclerosing Mesenteritis with Corticosteroids an… (10.1155/2001/462823)	References ORCID	85.80	51
31	Characterization of Inflammatory Bowel Disease in Elderly Pa… (10.1155/2015/136960)	References ORCID	85.80	51
32	Does the Level of Reproductive Knowledge Specific to Inflamm… (10.1155/2015/715354)	References ORCID	85.80	51
33	Toward Enteral Nutrition in the Treatment of Pediatric Crohn… (10.1155/2015/509497)	References ORCID	84.95	49
34	Transient Elastography for the Noninvasive Assessment of Liv… (10.1155/2010/153986)	References ORCID	84.06	47
35	Autoantibodies and Liver Disease: Uses and Abuses (10.1155/2010/431913)	References ORCID	84.06	47
36	Chronic Constipation: Current Treatment Options (10.1155/2011/360463)	References ORCID	84.06	47
37	Management of Thrombocytopenia in Advanced Liver Disease (10.1155/2014/532191)	References ORCID	83.60	46
38	Bouveret Syndrome: When There Are No Options (10.1155/2015/215643)	Abstract References ORCID	83.55	12
39	Program and Abstracts from the Canadian Digestive Diseases W… (10.1155/2016/4792898)	Abstract References ORCID	83.55	12
40	Molecular Signalling in Hepatocellular Carcinoma: Role of an… (10.1155/2015/172356)	References ORCID	83.14	45
41	The Feasibility and Reliability of Transient Elastography Us… (10.1155/2014/952684)	References ORCID	82.66	44
42	Peripheral Contributions to Visceral Hyperalgesia (10.1155/1999/730765)	References ORCID	81.67	42
43	Physician Attitudes toward the Use of Fecal Microbiota Trans… (10.1155/2014/403828)	References ORCID	81.67	42
44	Time to Make the Change from ‘Primary Biliary Cirrhosis’ to… (10.1155/2015/764684)	Abstract References ORCID	80.94	11
45	A Double‐Blind Randomized Study of Cisapride in the Treatmen… (10.1155/1997/314839)	References ORCID	80.64	40
46	Adherence to Guidelines: A National Audit of the Management… (10.1155/2014/252307)	References ORCID	80.64	40
47	Management of Irritable Bowel Syndrome: Novel Approaches to… (10.1155/1999/183697)	References ORCID	79.55	38
48	Recommendations on Chronic Constipation (Including Constipat… (10.1155/2007/848706)	References ORCID	79.55	38
49	Iron Overload Is Rare in Patients Homozygous for the H63D Mu… (10.1155/2014/468521)	References ORCID	79.55	38
50	Hepatocellular Carcinoma: Consensus, Controversies and Futur… (10.1155/2015/824263)	References ORCID	79.55	38